Richard Di Rocco, PhD

Industry Advisor

Dr. Richard Di Rocco is an accomplished pharmaceutical industry strategist, scientist, business leader and entrepreneur with strong organizational, selling, problem solving, communication and interpersonal skills.  He is a senior executive with an excellent track-record of leadership in biopharmaceutical R&D, business development, and creation of novel strategies for therapeutic repurposing of marketed prescription drugs and drug candidates.  Dr. Di Rocco is recognized as an expert on cerebrovascular disease, brain inflammation, diseases of aging, metabolic disorders, drug delivery,  and in vivo diagnostic imaging.  He did his graduate work in  Experimental Psychology and Neuroscience at New York University, and has worked in the area of biomedical neuroscience for over thirty years in industry and academia.  Dr. Di Rocco worked at the Cerebrovascular Research Center of the University of Pennsylvania’s Neurology Department, Bristol-Myers-Squibb and Cephalon before moving to BTG International, a business development company.  At BTG he was a Vice President responsible for assessment of in-licensing opportunities, in which capacity he traveled extensively throughout the US and Europe. Subsequently, he was a Co-Founder and Chief Scientific Officer of Enteron Therapeutics, a specialty pharmaceutical company focused on in-licensing drug products from European and Japanese companies for commercialization in the  United States.  Enteron Therapeutics obtained US rights to several important products, but failed to raise necessary capital during the period between 2008 to 2012.  Currently, Enteron operates as a holding company for intellectual property related to novel formulations and uses of L-Carnosine Zinc.  Dr. Di Rocco is an inventor on these patents.   He has also maintained a life-long interest in, and commitment to, teaching at the university level and has pursued this interest as an Adjunct Lecturer primarily at The University of Pennsylvania, where he teaches courses in Cognitive Neuroscience, Behavioral Neuroscience, Developmental Neurobiology, and a graduate level Cognitive Neuroscience Seminar on Artificial Intelligence.